Schedule 13D

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

SCHEDULE 13D

(Rule 13d-101)

 

 

Information to be Included in Statements Filed Pursuant

to Rules 13d-1(a) and Amendments thereto Filed

Pursuant to Rule 13d-2(a)

(Amendment No.    )*

 

 

 

 

SUNLINK HEALTH SYSTEMS, INC.


(Name of issuer)

 

 

Common Stock, without par value


(Title of class of securities)

 

 

86737U102


(CUSIP number)

 

 

COPY TO:

R. G. Barrett

North Atlantic Value LLP

Ryder Court

14 Ryder Street

London SW1Y 6QB, England

011-44-207-747-5640


(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

 

 

January 20, 2005


(Dates of Events which Require Filing of this Statement)

 

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check the following box.  ¨

 

Note.  Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7 for other parties to whom copies are to be sent.

 

*   The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

 

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

(Continued on following pages)

 

(Page 1 of 19 Pages)


CUSIP No. 86737U102

  SCHEDULE 13D  

Page 2 of 19

 

  1.  

NAME OF REPORTING PERSONS

I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)

 

            North Atlantic Value LLP

   
  2.  

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

(a)  ¨

(b)  x

   
  3.  

SEC USE ONLY

 

   
  4.  

SOURCE OF FUNDS

 

            AF

   
  5.  

CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e)

 

  ¨
  6.  

CITIZENSHIP OR PLACE OF ORGANIZATION

 

            England

   

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON

WITH

 

  7.    SOLE VOTING POWER

 

                0


  8.    SHARED VOTING POWER

 

                282,500


  9.    SOLE DISPOSITIVE POWER

 

                0


10.    SHARED DISPOSITIVE POWER

 

                282,500

11.  

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

            282,500

   
12.  

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*

 

 

¨

 

13.  

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

 

            4.0%

   
14.  

TYPE OF REPORTING PERSON*

 

            OO, IA

   

 

* SEE INSTRUCTIONS BEFORE FILLING OUT!


CUSIP No. 86737U102

  SCHEDULE 13D  

Page 3 of 19

 

  1.  

NAME OF REPORTING PERSONS

I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)

 

            Christopher Harwood Bernard Mills

   
  2.  

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

(a)  ¨

(b)  x

   
  3.  

SEC USE ONLY

 

   
  4.  

SOURCE OF FUNDS

 

            AF

   
  5.  

CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e)

 

  ¨
  6.  

CITIZENSHIP OR PLACE OF ORGANIZATION

 

            England

   

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON

WITH

 

  7.    SOLE VOTING POWER

 

                0


  8.    SHARED VOTING POWER

 

                282,500


  9.    SOLE DISPOSITIVE POWER

 

                0


10.    SHARED DISPOSITIVE POWER

 

                282,500

11.  

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

            282,500

   
12.  

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*

 

 

¨

 

13.  

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

 

            4.0%

   
14.  

TYPE OF REPORTING PERSON*

 

            IN

   

 

* SEE INSTRUCTIONS BEFORE FILLING OUT!


CUSIP No. 86737U102

  SCHEDULE 13D  

Page 4 of 19

 

  1.  

NAME OF REPORTING PERSONS

I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)

 

            American Opportunity Trust plc

   
  2.  

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

(a)  ¨

(b)  x

   
  3.  

SEC USE ONLY

 

   
  4.  

SOURCE OF FUNDS

 

            WC

   
  5.  

CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e)

 

  ¨
  6.  

CITIZENSHIP OR PLACE OF ORGANIZATION

 

            England

   

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON

WITH

 

  7.    SOLE VOTING POWER

 

                0


  8.    SHARED VOTING POWER

 

                282,500


  9.    SOLE DISPOSITIVE POWER

 

                0


10.    SHARED DISPOSITIVE POWER

 

                282,500

11.  

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

            282,500

   
12.  

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*

 

 

¨

 

13.  

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

 

            4.0%

   
14.  

TYPE OF REPORTING PERSON*

 

            IV

   

 

* SEE INSTRUCTIONS BEFORE FILLING OUT!


CUSIP No. 86737U102

  SCHEDULE 13D  

Page 5 of 19

 

  1.  

NAME OF REPORTING PERSONS

I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)

 

            Gildea Management Company

   
  2.  

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

(a)  ¨

(b)  x

   
  3.  

SEC USE ONLY

 

   
  4.  

SOURCE OF FUNDS

 

            AF

   
  5.  

CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e)

 

  ¨
  6.  

CITIZENSHIP OR PLACE OF ORGANIZATION

 

            Delaware

   

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON

WITH

 

  7.    SOLE VOTING POWER

 

                0


  8.    SHARED VOTING POWER

 

                105,000


  9.    SOLE DISPOSITIVE POWER

 

                0


10.    SHARED DISPOSITIVE POWER

 

                105,000

11.  

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

            105,000

   
12.  

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*

 

 

¨

 

13.  

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

 

            1.5%

   
14.  

TYPE OF REPORTING PERSON*

 

            CO, IA

   

 

* SEE INSTRUCTIONS BEFORE FILLING OUT!


CUSIP No. 86737U102

  SCHEDULE 13D  

Page 6 of 19

 

  1.  

NAME OF REPORTING PERSONS

I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)

 

            John W. Gildea

   
  2.  

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

(a)  ¨

(b)  x

   
  3.  

SEC USE ONLY

 

   
  4.  

SOURCE OF FUNDS

 

            AF, PF

   
  5.  

CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e)

 

  ¨
  6.  

CITIZENSHIP OR PLACE OF ORGANIZATION

 

            USA

   

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON

WITH

 

  7.    SOLE VOTING POWER

 

                2,800


  8.    SHARED VOTING POWER

 

                105,000


  9.    SOLE DISPOSITIVE POWER

 

                2,800


10.    SHARED DISPOSITIVE POWER

 

                105,000

11.  

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

            107,800

   
12.  

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*

 

 

¨

 

13.  

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

 

            1.5%

   
14.  

TYPE OF REPORTING PERSON*

 

            IN

   

 

* SEE INSTRUCTIONS BEFORE FILLING OUT!


CUSIP No. 86737U102

  SCHEDULE 13D  

Page 7 of 19

 

  1.  

NAME OF REPORTING PERSONS

I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)

 

            Axia Value Partners LLC

   
  2.  

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

(a)  ¨

(b)  x

   
  3.  

SEC USE ONLY

 

   
  4.  

SOURCE OF FUNDS

 

            WC

   
  5.  

CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e)

 

  ¨
  6.  

CITIZENSHIP OR PLACE OF ORGANIZATION

 

            Delaware

   

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON

WITH

 

  7.    SOLE VOTING POWER

 

                0


  8.    SHARED VOTING POWER

 

                105,000


  9.    SOLE DISPOSITIVE POWER

 

                0


10.    SHARED DISPOSITIVE POWER

 

                105,000

11.  

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

            105,000

   
12.  

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*

 

 

¨

 

13.  

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

 

            1.5%

   
14.  

TYPE OF REPORTING PERSON*

 

            OO

   

 

* SEE INSTRUCTIONS BEFORE FILLING OUT!


STATEMENT ON SCHEDULE 13D

 

This Statement on Schedule 13D (the “Statement”) is filed on behalf of the Filing Parties (defined below).

 

Item 1. Security and Issuer.

 

The class of equity securities to which this Statement relates is the common stock, without par value (the “Common Stock”), of Sunlink Health Systems, Inc., an Ohio corporation (the “Company”). The principal executive offices of the Company are located at 900 Circle 75 Parkway, Suite 1120, Atlanta, Georgia 30339.

 

Item 2. Identity and Background.

 

2 (a-c,f).

 

  I. Filing Parties:

 

This Statement is filed on behalf of the following persons, who are collectively referred to as the “Filing Parties:”

 

  1. North Atlantic Value LLP (“North Atlantic Value”) is a limited liability partnership organized under the laws of England with its principal office and business at Ryder Court, 14 Ryder Street, London SW1Y 6QB England. North Atlantic Value is a firm authorized by the United Kingdom’s Financial Services Authority and is principally engaged in the business of investment management of active value and private equity investments, as well as to its private clients.

 

  2. Christopher Harwood Bernard Mills is a British citizen whose business address is Ryder Court, 14 Ryder Street, London SW1Y 6QB England. His principal employment includes service as executive director of North Atlantic Smaller Companies Investment Trust (“NASCIT”), as chief executive of American Opportunity Trust plc (“American Opportunity Trust”), as a director of J O Hambro Capital Management Group Limited, J O Hambro Capital Management Limited, The Trident North Atlantic Fund, Oryx International Growth Fund Limited, Acquisitor plc and Acquisitor Holdings (Bermuda) Ltd., and as co-investment adviser to NASCIT.

 

  3. American Opportunity Trust is a corporation organized under the laws of England with its principal office and business at Ryder Court, 14 Ryder Street, London SW1Y 6QB England. American Opportunity Trust is a publicly-held investment trust company. North Atlantic Value serves as investment manager to American Opportunity Trust.

 

  4. Gildea Management Company is a corporation organized under the laws of the State of Delaware with its principal office and business address at PO Box 938, 65 Vitti Street, New Canaan, Connecticut. Gildea Management Company is principally engaged in the business of investment management.

 

Page 8 of 19


  5. John W. Gildea is a U.S. citizen whose principal business address is PO Box 938, 65 Vitti Street, New Canaan, Connecticut. His principal employment includes service as the managing director of Gildea Management Company and as a director of American Opportunity Trust.

 

  6. Axia Value Partners LLC (“Axia Value Partners”) is a limited liability company organized under the laws of the State of Delaware with its principal office and business address at PO Box 938, 65 Vitti Street, New Canaan, Connecticut. Axia Value Partners is a private equity fund. Gildea Management Company serves as the investment manager of Axia Value Partners.

 

II. Executive Officers and Directors:

 

In accordance with the provisions of General Instruction C to Schedule 13D, information concerning the executive officers and directors of the Filing Parties is included in Schedule A hereto and is incorporated by reference herein.

 

(d) Criminal Proceedings

 

During the last five years, neither the Filing Parties (or a controlling entity thereof) nor any executive officer or director of any of the Filing Parties (or a controlling entity thereof) has been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors).

 

(e) Civil Securities Law Proceedings

 

During the last five years, neither the Filing Parties (or a controlling entity thereof) nor any executive officer or director of any of the Filing Parties (or a controlling entity thereof) has been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.

 

Item 3. Source and Amount of Funds or Other Consideration.

 

The aggregate purchase price of the 282,500 shares of Common Stock beneficially held by American Opportunity Trust is $1,536,771 (exclusive of brokerage fees and commissions). All of the shares of Common Stock beneficially held by American Opportunity Trust were paid for using its working capital funds.

 

The aggregate purchase price of the 105,000 shares of Common Stock beneficially held by Axia Value Partners is $576,250 (exclusive of brokerage fees and commissions). All of the shares of Common Stock beneficially held by Axia Value Partners were paid for using its working capital funds.

 

Page 9 of 19


The aggregate purchase price of the 2,800 shares of Common Stock beneficially held solely by John W. Gildea is $14,280 (exclusive of brokerage fees and commissions). All of the shares of Common Stock beneficially held solely by Mr. Gildea were paid for using his personal funds.

 

Item 4. Purpose of Transaction.

 

The Filing Parties believe that the shares of Common Stock of the Company are undervalued and represent an attractive investment opportunity and they are considering pursuing any and all of the actions enumerated below.

 

The Filing Parties may take such actions with respect to their investment in the Company as they deem appropriate, including without limitation: (i) having open communications with the Company’s management in order to monitor their efforts to increase shareholder value, (ii) purchasing additional shares of Common Stock in the open market or otherwise, (iii) seeking a change of control of the Company through various means, including without limitation, an extraordinary corporate transaction, such as a merger, reorganization, recapitalization or tender offer, (iv) seeking to amend the Company’s charter and by-laws, (v) seeking to elect a slate of directors to the Company’s board of directors and (vi) presenting proposals for stockholders’ consideration at an annual or special meeting of the Company’s stockholders.

 

Should the Company fail to define a clear strategy to maximize shareholder value, the Filing Parties may consider a means by which some or all of the directors may be removed from the board of directors.

 

In addition, the Filing Parties believe it is in the interest of all shareholders if either the current board or a new board immediately appoint an independent firm of investment bankers to find ways to maximize shareholder value.

 

The Filing Parties may also participate in discussions with potential purchasers of their shares of Common Stock, sell some or all of their shares of Common Stock in the open market or through privately negotiated transactions, or change their intention with respect to any and all of the matters referred to above.

 

Page 10 of 19


Item 5. Interest in Securities of the Issuer.

 

(a)-(b) The aggregate number and percentage of the outstanding Common Stock of the Company beneficially owned (i) by each of the Filing Parties, and (ii) to the knowledge of the Filing Parties, by each other person who may be deemed to be a member of the group, is as follows:

 

Filing Party


   Aggregate
Number of
Shares


   Number of
Shares:
Sole
Power to
Vote


  

Number of
Shares:
Shared
Power to

Vote


   Number of
Shares:
Sole
Power to
Dispose


   Number of
Shares:
Shared
Power to
Dispose


   Approximate
Percentage*


 

North Atlantic Value

   282,500    0    282,500    0    282,500    4.0 %

Christopher H. B. Mills

   282,500    0    282,500    0    282,500    4.0 %

American Opportunity Trust

   282,500    0    282,500    0    282,500    4.0 %

John W. Gildea

   107,800    2,800    105,000    2,800    105,000    1.5 %

Gildea Management Company

   105,000    0    105,000    0    105,000    1.5 %

Axia Value Partners

   105,000    0    105,000    0    105,000    1.5 %

 

* Based on 7,078,665 shares of Common Stock, without par value, outstanding as of November 11, 2004, which is based on information reported in the Company’s 10-Q, for the period ended September 30, 2004.

 

(c) During the past 60 days, the Filing Parties effected no transactions in the Common Stock other than those set forth in the following table:

 

Sunlink Health Systems, Inc.

 

   Trades During Past 60 Days

Filing Party


   Date

   No. of Shares

   Price
(US$)


  

Broker


American Opportunity Trust

   11/30/04    5,500    $ 5.25   

Oscar Gruss

American Opportunity Trust

   12/02/04    3,000    $ 5.25   

Oscar Gruss

American Opportunity Trust

   12/08/04    4,800    $ 5.25   

Oscar Gruss

American Opportunity Trust

   12/09/04    1,600    $ 5.25   

Oscar Gruss

American Opportunity Trust

   01/20/05    215,000    $ 5.50   

Oscar Gruss

Gildea Management Company

   12/03/04    5,000    $ 5.25   

Oscar Gruss

Gildea Management Company

   01/20/05    100,000    $ 5.50   

Oscar Gruss

 

All of the above transactions were effected on the open market and were purchases.

 

Page 11 of 19


(d) No person other than the Filing Parties is known to have the right to receive, or the power to direct the receipt of dividends from, or the proceeds from the sale of, such shares of Common Stock.

 

Item 6. Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer.

 

North Atlantic Value is the investment manager to American Opportunity Trust and as such it has the authority to vote or dispose of the Common Stock. Christopher Harwood Bernard Mills is the Chief Executive of American Opportunity Trust. Christopher Harwood Bernard Mills is also a partner of North Atlantic Value. Gildea Management Company is the investment manager to Axia Value Partners and as such it has the authority to vote or dispose of the Common Stock. John W. Gildea is a managing director of Gildea Management Company and is also a director of American Opportunity Trust.

 

Item 7. Material to be Filed as Exhibits.

 

99.1    Joint Filing Agreement.

 

Page 12 of 19


SIGNATURE

 

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

Dated: January 24, 2005

 

NORTH ATLANTIC VALUE LLP
By:  

/s/ R. G. Barrett


Name:   R. G. Barrett
Title:   Compliance Officer
    Executed on behalf of the Filing Parties pursuant to the Joint Filing Agreement, filed herewith.

 

Page 13 of 19


Schedule A

 

Information Concerning Directors and Executive Officers of the Filing Parties

 

The following table sets forth certain information concerning each of the members and partners of North Atlantic Value LLP as of the date hereof.

 

Members:

   

Name:

  J O Hambro Capital Management Group Limited
    (Member)

Business Address:

  Ryder Court
    14 Ryder Street
    London SW1Y 6QB
    England

Name:

  J O Hambro Capital Management Limited
    (Member)

Business Address:

  Ryder Court
    14 Ryder Street
    London SW1Y 6QB
    England

Partners:

   

Name:

  Christopher Harwood Bernard Mills
    (Partner)

Citizenship:

  British

Business Address:

  Ryder Court
    14 Ryder Street
    London SW1Y 6QB
    England

Principal Occupation:

  Chief Executive, American Opportunity Trust
    Director, Trident North Atlantic
    Director, J O Hambro Capital Management Limited
    Partner, North Atlantic Value LLP


Name:

  Nichola Pease
    (Partner)

Citizenship:

  British

Business Address:

  Ryder Court
    14 Ryder Street
    London SW1Y 6QB
    England

Principal Occupation:

  Director and Chief Executive, J O Hambro Capital Management Limited
    Partner, North Atlantic Value LLP

Name:

  Jeremy James Brade
   

(Partner)

Citizenship:

  British

Business Address:

  Ryder Court
    14 Ryder Street
    London SW1Y 6QB
    England

Principal Occupation:

  Director, J O Hambro Capital Management Limited
    Partner, North Atlantic Value LLP

Name:

  Fay Elizabeth Foster
    (Partner)

Citizenship:

  British

Business Address:

  Ryder Court
    14 Ryder Street
    London SW1Y 6QB
    England

Principal Occupation:

  Partner, North Atlantic Value LLP

Name:

  Charles Dominic Robert Clifford Cyrus
    (Partner)

Citizenship:

  British

Business Address:

  Ryder Court
    14 Ryder Street
    London SW1Y 6QB
    England

Principal Occupation:

  Partner, North Atlantic Value LLP

Name:

  Basil David Postan
    (Partner)

Citizenship:

  British

Business Address:

  Ryder Court
    14 Ryder Street
    London SW1Y 6QB
    England

Principal Occupation:

  Director, J O Hambro Capital Management Limited
    Partner, JOHCM Alternative Investments LLP


The following table sets forth certain information concerning each of the directors and executive officers of American Opportunity Trust plc as of the date hereof.

 

Name:

 

R. Alexander Hammond-Chambers

(Chairman)

Citizenship:

  British

Business Address:

 

29 Rutland Square

Edinburgh EH1 2BW

Scotland

Principal Occupation:

  Non-Executive Director, American Opportunity Trust

Name:

 

Christopher Harwood Bernard Mills

(Chief Executive)

Citizenship:

  British

Business Address:

 

Ryder Court

14 Ryder Street

London SW1Y 6QB

England

Principal Occupation:

 

Chief Executive, American Opportunity Trust

Director, Trident North Atlantic

Director, J O Hambro Capital Management Limited

Partner, North Atlantic Value LLP

Name:

 

John W. Gildea

(Director)

Citizenship:

  USA

Business Address:

 

Gildea Management Company

PO Box 938

65 Vitti Street

New Canaan, Connecticut 06840

USA

Principal Occupation:

  Managing Director, Gildea Management Company


Name:

 

The Hon. James J. Nelson

(Director)

Citizenship:

  British

Business Address:

 

Graphite Capital Management LTD1

4th Floor

Berkeley Square House

Berkeley Square

London W1X 5PA

England

Principal Occupation:

  Non-Executive Director, Graphite Capital Management LTD

Name:

 

Iain Tulloch

(Director)

Citizenship:

  British

Business Address:

 

Swallow Ha-Symington

Ayrohire Scotland

KA1 5PN

Principal Occupation:

  Non-Executive Director, American Opportunity Trust

Name:

 

Philip Ehrman

(Director)

Citizenship:

  British

Business Address:

 

Gartmore Investment Management Ltd.2

Gartmore House

8 Fenchurch Place

London EC3M 4PH

England

Principal Occupation:

  Head of Pacific & Emerging Markets, Gartmore Investment Management Ltd.

 

1 Graphite Capital Management LTD is principally engaged in the investment management business.
2 Gartmore Investment Management Limited is principally engaged in the investment management business.


The following table sets forth certain information concerning the sole director of Gildea Management Company as of the date hereof.

 

Name:

 

John W. Gildea

(Managing Director)

Citizenship:

  USA

Business Address:

 

Gildea Management Company

PO Box 938

65 Vitti Street

New Canaan, Connecticut 06840

USA

Principal Occupation:

  Managing Director, Gildea Management Company


The following table sets forth certain information concerning the sole director of Axia Value Partners LLC as of the date hereof.

 

Name:

 

John W. Gildea

(Sole Director)

Citizenship:

  USA

Business Address:

 

Gildea Management Company

PO Box 938

65 Vitti Street

New Canaan, Connecticut 06840

USA

Principal Occupation:

  Managing Director, Gildea Management Company


Exhibit Index

 

The following documents are filed herewith or incorporated herein by reference:

 

Exhibit


   Page

(99.1) Joint Filing Agreement dated as of January 24, 2005 among the Filing Parties.

   Filed herewith.


EXHIBIT 99.1

 

JOINT FILING AGREEMENT

 

The undersigned hereby agree that the Statement on Schedule 13D dated January 24, 2005 with respect to the shares of Common Stock, without par value, of Sunlink Health Systems, Inc. and any further amendments thereto executed by each or any of us shall be filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended.

 

This Agreement may be executed in separate counterparts, each of which shall be deemed an original, but all of which shall constitute one and the same instrument.

 

Date: January 24, 2005

     

NORTH ATLANTIC VALUE LLP

       

/s/ R. G. Barrett


        Name:  

R. G. Barrett

        Title:  

Compliance Officer

Date: January 24, 2005

     

CHRISTOPHER H. B. MILLS

       

/s/ Christopher H. B. Mills


Date: January 24, 2005

     

AMERICAN OPPORTUNITY TRUST PLC

       

/s/ Christopher H. B. Mills


        Name:  

Christopher H. B. Mills

        Title:  

Chief Executive

Date: January 24, 2005

     

GILDEA MANAGEMENT COMPANY

       

/s/ John W. Gildea


        Name:  

John W. Gildea

        Title:  

Managing Director

Date: January 24, 2005

     

JOHN W. GILDEA

       

/s/ John W. Gildea


Date: January 24, 2005

     

AXIA VALUE PARTNERS LLC

       

/s/ John W. Gildea


        Name:  

John W. Gildea

        Title:  

Director